Search results
Castle Biosciences Inc (CSTL) Reports Robust Revenue Growth and Improved Margins in 2023
GuruFocus.com via Yahoo Finance· 2 months agoRevenue Growth: Full-year 2023 revenue reached $220 million, marking a 60% increase from 2022. Test...
Does Castle Bioscience (CSTL) Have Robust Growth Prospects?
Insider Monkey via Yahoo Finance· 1 month agoNext Century Growth Investors, LLC, an investment Management Company, released its “SMID Cap Growth...
When Should You Buy Castle Biosciences, Inc. (NASDAQ:CSTL)?
Simply Wall St. via Yahoo Finance· 2 years agoCastle Biosciences, Inc. (NASDAQ:CSTL), might not be a large cap stock, but it saw a significant...
How Much Upside is Left in Castle Biosciences, Inc. (CSTL)? Wall Street Analysts Think 67.01%
Zacks via Yahoo Finance· 4 months agoThe mean of analysts' price targets for Castle Biosciences, Inc. (CSTL) points to a 67% upside in...
Castle Biosciences, Inc. (NASDAQ:CSTL) is largely controlled by institutional shareholders who own...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Significantly high institutional ownership implies Castle Biosciences' stock price is...
Castle Biosciences, Inc. (NASDAQ:CSTL) Reported Earnings Last Week And Analysts Are Already...
Simply Wall St. via Yahoo Finance· 2 months agoCastle Biosciences, Inc. (NASDAQ:CSTL) investors will be delighted, with the company turning in some...
Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoCastle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of 89.66% and 22.67%,...
Earnings Preview: Castle Biosciences, Inc. (CSTL) Q2 Earnings Expected to Decline
Zacks via Yahoo Finance· 2 years agoCastle Biosciences, Inc. (CSTL) doesn't possess the right combination of the two key ingredients for...
Calculating The Intrinsic Value Of Castle Biosciences, Inc. (NASDAQ:CSTL)
Simply Wall St. via Yahoo Finance· 2 years agoToday we will run through one way of estimating the intrinsic value of Castle Biosciences, Inc....
Increasing losses over year doesn't faze Castle Biosciences (NASDAQ:CSTL) investors as stock jumps...
Simply Wall St. via Yahoo Finance· 1 year agoCastle Biosciences, Inc. (NASDAQ:CSTL) shareholders should be happy to see the share price up 11% in...